Published in Drug Law Weekly, August 5th, 2008
The verdict for the class of minority shareholders is in favor of approximately 1185 shareholders holding 1,195,470 shares. The court has previously indicated that it may value those shares at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.